SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,103.93 |
| Enterprise Value ($M) | 979.76 |
| Book Value ($M) | 78.60 |
| Book Value / Share | 1.64 |
| Price / Book | 14.05 |
| NCAV ($M) | 56.88 |
| NCAV / Share | 1.19 |
| Price / NCAV | 19.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.61 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.74 |
| Current Ratio | 1.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 134.00 |
| Assets | 155.72 |
| Liabilities | 77.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -105.96 |
| Net Income | -97.22 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -82.03 |
| Cash from Investing | -0.41 |
| Cash from Financing | 2.56 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.51 | 5.81 | |
| 13G/A | Barbier Remi | 5.70 | 20.45 | |
| 13G/A | BlackRock Inc. | 7.20 | 18.44 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| Item 4. Mine Safety Disclosures Item 5. Other Information | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 154,928 | 643,749 | 24.07 | |
| 226,516 | 867,788 | 26.10 | |
| 306,132 | 1,799,007 | 17.02 | |
| 136,879 | 592,902 | 23.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RVPH – Reviva Pharmaceuticals Holdings, Inc. | RZLT – Rezolute, Inc. |
| SABS – SAB Biotherapeutics, Inc. | SBFM – Sunshine Biopharma, Inc. |
| SCLX – Scilex Holding Company |